You are here

Our science / Clinical Trials / Find a Trial / NCT00141349

Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction

Back to Search Print Save as PDF Bookmark Trial

NCT00141349

Last updated on March 14, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Birmingham, Alabama, 35205 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Impotence
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Erectile dysfunction as defined by DSM-IV. Patients should have been PDE5 inhibitor
respondents

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Alpha blockers and Nitrates of any preparation

NCT00141349
Pfizer
Completed
Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now